Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.

MC Bateson, D Maclean, JR Evans… - British Journal of …, 1978 - Wiley Online Library
MC Bateson, D Maclean, JR Evans, IA Bouchier
British Journal of Clinical Pharmacology, 1978Wiley Online Library
1 Ten consecutive patients with hypertriglyceridaemia who adhered to a low carbohydrate
diet without complete control of serum triglycerides were started on chenodeoxycholic acid
750 mg daily and followed monthly for 6 months. Nine of these patients were then followed
for a further month on placebo capsules and thereafter monthly for a further 6 months on
clofibrate 2 g daily. 2 The mean serum triglyceride level fell by 36% after dietary treatment
alone (P less than 0.05) and by 47% from initial values on diet plus chenodeoxycholic acid …
1 Ten consecutive patients with hypertriglyceridaemia who adhered to a low carbohydrate diet without complete control of serum triglycerides were started on chenodeoxycholic acid 750 mg daily and followed monthly for 6 months. Nine of these patients were then followed for a further month on placebo capsules and thereafter monthly for a further 6 months on clofibrate 2 g daily. 2 The mean serum triglyceride level fell by 36% after dietary treatment alone (P less than 0.05) and by 47% from initial values on diet plus chenodeoxycholic acid (P less than 0.01). In the nine patients who proceeded to clofibrate therapy there was a rise in triglyceride levels on placebo capsules to the level achieved by diet alone, and a further fall on diet plus clofibrate of 47% of initial values (P less than 0.05). 3 Chenodeoxycholic acid therapy is effective in the management of hypertriglyceridaemia not completely cured by dietary measures, and may be as efficacious as clofibrate.
Wiley Online Library